Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-19

Clinical Trial Update: Donor Simvastatin Treatment in Organ Transplantation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on donor simvastatin treatment in organ transplantation across Phase 2 and Phase 3, completed; conditions listed include heart, respirator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Heart Failure, Respiratory Failure | Phase 2, Phase 3 | Status: COMPLETED